Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Moodys
Federal Trade Commission
QuintilesIMS
Covington
US Army
Teva
UBS
Chubb

Generated: June 23, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,667,794

« Back to Dashboard

Summary for Patent: 5,667,794
Title: Heartburn treatment
Abstract:A method for treating a patient suffering from heartburn and having no substantial esophageal erosion, comprising administering to the patient a composition comprising an amount of famotidine between about 5 mg and 10 mg. In one embodiment, the amount of famotidine is about 5 mg. In another embodiment, the amount of famotidine is about 10 mg. A method for treating a patient suffering from heartburn and having no substantial esophageal erosion, comprising administering to the patient a composition comprising an amount of famotidine between about 5 mg and 10 mg, and an antacid. In one embodiment, the amount of famotidine is about 5 mg. In another embodiment, the amount of famotidine is about 10 mg.
Inventor(s): Simon; Thomas (Berwyn, PA), Berlin; Roger (Haverford, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/710,078
Patent Claims: 1. A method for treating a human suffering from heartburn and having no substantial esophageal erosion, comprising administering to the patient a composition comprising an amount of famotidine between about 5 mg and 10 mg sufficient to treat heartburn, wherein the composition does not contain an antacid.

2. A method of claim 1, wherein the amount of famotidine is about 5 mg.

3. A method of claim 1, wherein the amount of famotidine is about 10 mg.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Deloitte
Moodys
Cerilliant
Julphar
Chinese Patent Office
Citi
Accenture
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.